Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

NVCTNVCT
6 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in NUVECTIS PHARMA INC

GOLDMAN SACHS GROUP INC holds 20,480 shares of NVCT (NUVECTIS PHARMA INC), worth $376,627 as of 2026-Q2. The position was decreased (-50.2% shares).

Current Value

$376,627

Current Shares

20,480

Total Value Change

-$68,963

Total Shares Change

-25,128

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
20,480
-50.2%
$376,6270.0%$18.39
0
2026-Q1
Increased
41,124
+55.2%
$317,8890.0%$8.71
23
2025-Q4
Decreased
26,503
-41.3%
$200,0980.0%$7.38
0
2025-Q3
New
45,163
-
$271,8810.0%$5.92
36
2025-Q2
Exited
0
-100.0%
$00.0%$7.55
0
2025-Q1
New
45,608
-
$445,5900.0%$10.46
33

Other major holders of NVCT: BlackRock, Inc., VANGUARD CAPITAL MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used